GlassScriptPhysician profile
Leonora M Genoble
NPI 1598987158
$1,085.11
in general payments reported to CMS, 2019-2025
15 companies · $83.29 in 2025
The $83.29 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $305 · 2022: $243 · 2023: $195 · 2024: $259 · 2025: $83.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $397.78 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.79 | 2022-2024 | Xifaxan, Trulance, Plenvu |
| Abbvie INC. | $105.45 | 2024-2025 | |
| Viiv Healthcare Company | $99.37 | 2021-2024 | Dovato |
| Janssen Biotech, INC. | $59.25 | 2021-2024 | Darzalex, Tecvayli, Talvey |
| Braintree Laboratories, INC. | $54.78 | 2021-2025 | Suflave, Sutab |
| Pfizer INC. | $43.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.76 | 2023-2024 | Ninlaro, Entyvio |
| Intercept Pharmaceuticals, INC. | $31.80 | 2021-2022 | |
| Exact Sciences Corporation | $27.99 | 2025 | Cologuard Collection Kit |
| Rigel Pharmaceuticals, INC. | $23.04 | 2023 | Rezlidhia, Tavalisse |
| Blueprint Medicines Corporation | $19.99 | 2023 | Ayvakit |
| Nestle Healthcare Nutrition INC. | $16.67 | 2021 | |
| Daiichi Sankyo INC. | $15.62 | 2024 | Injectafer |
| Gilead Sciences, INC. | $12.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonora Genoble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.